Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150

Hopkins, AM; Kichenadasse, G; McKinnon, RA; Abuhelwa, AY; Logan, JM; Badaoui, S; Karapetis, CS; Rowland, A; Sorich, MJ

Hopkins, AM (通讯作者),Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia.

BRITISH JOURNAL OF CANCER, 2022; 126 (1): 42

Abstract

Background Proton pump inhibitors (PPIs) are commonly used concomitant to cancer treatment and they induce gut microbiota changes. It is increasingly ......

Full Text Link